Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
Background: Concern for the development of extrapyramidal side effects (EPSEs) represents a barrier to the routine use of long-acting injectable (LAI) antipsychotic medication in patients with first-episode schizophrenia (FES). Flupenthixol decanoate is a first-generation antipsychotic, which is rea...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2021-01-01
|
| Series: | South African Journal of Psychiatry |
| Subjects: | |
| Online Access: | https://sajp.org.za/index.php/sajp/article/view/1568 |